← Back to Search
Tumor Microenvironment: Challenges And Opportunities In Targeting Metastasis Of Triple Negative Breast Cancer.
K. Deepak, R. K. Vempati, G. P. Nagaraju, V. Dasari, S. Nagini, D. N. Rao, Rama Rao Malla
Published 2020 · Medicine
Download PDFAnalyze on Scholarcy
Triple negative breast cancer (TNBC) is most aggressive subtype of breast cancers with high probability of metastasis as well as lack of specific targets and targeted therapeutics. TNBC is characterized with unique tumor microenvironment (TME), which differs from other subtypes. TME is associated with induction of proliferation, angiogenesis, inhibition of apoptosis and immune system suppression, and drug resistance. Exosomes are promising nanovesicles, which orchestrate the TME by communicating with different cells within TME. The components of TME including transformed ECM, soluble factors, immune suppressive cells, epigenetic modifications and re-programmed fibroblasts together hamper antitumor response and helps progression and metastasis of TNBCs. Therefore, TME could be a therapeutic target of TNBC. The current review presents latest updates on the role of exosomes in modulation of TME, approaches for targeting TME and combination of immune checkpoint inhibitors and target chemotherapeutics. Finally, we also discussed various phytochemicals that alter genetic, transcriptomic and proteomic profiles of TME along with current challenges and future implications. Thus, as TME is associated with the hallmarks of TNBC, the understanding of the impact of different components can improve the clinical benefits of TNBC patients.
This paper references
Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer
Yulia Liubomirski (2019)
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Varun Sasidharan Nair (2018)
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
F. Geyer (2011)
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses
F. Hossain (2018)
The mazy case of Notch and immunoregulatory cells
P. Grazioli (2017)
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.
L. Rhodes (2012)
Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy
M. Tahmasebi Birgani (2017)
Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer
Yulia Liubomirski (2019)
Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome
S. Adams (2013)
Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
S. Tsukumo (2018)
Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations
M. Chan (2018)
Targeting metabolism to regulate immune responses in autoimmunity and cancer
C. H. Patel (2019)
Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer
Liviuţa Budişan (2017)
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
D. Silver (2010)
Erratum: Methods for detecting host genetic modifiers of tumor vascular function using dynamic near-infrared fluorescence imaging: errata.
Jaidip M Jagtap (2018)
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
R. Dent (2007)
TIC10/ONC201-a potential therapeutic in glioblastoma.
G. Karpel-Massler (2017)
A Mutant Receptor Tyrosine Phosphatase, CD148, Causes Defects in Vascular Development
T. Takahashi (2003)
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population.
N. Bhola (2016)
The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions
B. Smits (2011)
Horizons of nanotechnology applications in female specific cancers.
B. Rajitha (2019)
The hedgehog pathway in triple‐negative breast cancer
Joyce G. Habib (2016)
Subtypes of breast cancer show preferential site of relapse.
M. Smid (2008)
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
H. Sihto (2011)
Accessories to the crime: functions of cells recruited to the tumor microenvironment.
D. Hanahan (2012)
Regulation of chromatin by histone modifications
Andrew J. Bannister (2011)
Tumor Microenvironment: A New Treatment Target for Cancer
Ming-Ju Tsai (2014)
Tumor-derived extracellular vesicles in breast cancer: from bench to bedside.
Hong-xia Wang (2019)
Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer
S. Hunter (2019)
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab
R. Basho (2017)
A Review of the Role of Wnt in Cancer Immunomodulation
W. Goldsberry (2019)
Tumor microenvironment: Sanctuary of the devil.
Lanlan Hui (2015)
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
D. Klein (2018)
CAR T cell immunotherapy for human cancer
C. June (2018)
Characterization of a selective CaMKII peptide inhibitor.
I. Gomez-Monterrey (2013)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang (2015)
The metastatic microenvironment of breast cancer: clinical implications.
R. Coleman (2013)
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
Cecilia Lässer (2010)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin (2018)
Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density.
T. L. Le Voyer (2001)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
P. Savas (2016)
Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy
Jiabei He (2019)
The immune score as a new possible approach for the classification of cancer
J. Galon (2011)
Hallmarks of Cancer: The Next Generation
D. Hanahan (2011)
Genetic Modifiers of the Breast Tumor Microenvironment.
M. J. Flister (2018)
MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities.
A. Evans-Knowell (2017)
Biomarkers for immune checkpoint inhibitors: The importance of tumor topography and the challenges to cytopathology
D. P. Clark (2018)
The blockade of immune checkpoints in cancer immunotherapy
D. Pardoll (2012)
The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment
Zhongrun Qian (2015)
Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
J. Duan (2018)
Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
B. Mlecnik (2011)
The fibromatosis signature defines a robust stromal response in breast carcinoma
A. Beck (2008)
The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity
T. Moroishi (2016)
3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation
Yucui Jin (2011)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
S. Liu (2014)
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz (2015)
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Y. Liu (2016)
Targeting tumour microenvironment by tyrosine kinase inhibitor
Hor-Yue Tan (2018)
Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells.
Venkata Charepalli (2015)
EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis
J. Son (2014)
Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
Chunling Ma (2012)
Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women
Tess O’Meara (2019)
Epigenetic control of the tumor microenvironment.
D. Marks (2016)
E-103 Inflammation-driven networks in the regulation of breast cancer progression
A. Ben-Baruch (2019)
Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.
Yuelong Liu (2010)
Therapeutic targets of triple‐negative breast cancer: a review
V. Jamdade (2015)
Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies.
M. Record (2014)
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
R. Thakur (2015)
Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer.
Y. Tao (2011)
The fate of chemoresistance in triple negative breast cancer (TNBC)
E. A. O'Reilly (2015)
Modeling Therapy Resistance in BRCA1/2-Mutant Cancers
Amy Dréan (2017)
EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release.
K. J. Suh (2017)
Direct Effect of Rituximab in B-Cell–Derived Lymphoid Neoplasias: Mechanism, Regulation, and Perspectives
C. Bezombes (2011)
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
N. Rostami (2019)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
A. Morel (2008)
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
C. C. Wong (2011)
2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
L. Nagaprashantha (2019)
Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC).
L. Wein (2017)
The extracellular matrix modulates the hallmarks of cancer
M. Pickup (2014)
Indian gooseberry (Emblica officinalis Gaertn.) suppresses cell proliferation and induces apoptosis in human colon cancer stem cells independent of p53 status via suppression of c-Myc and cyclin D1
Ramakrishna Vadde (2016)
Herbacetin inhibits inducible nitric oxide synthase via JNK and nuclear factor-κB in LPS-stimulated RAW264.7 cells.
L. Li (2015)
Curcumin - A Novel Therapeutic Agent In The Prevention Of Colorectal Cancer.
M. Gupta (2019)
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
T. Wang (2014)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
R. Fodde (2007)
Induction of HOXA9 expression in three-dimensional organotypic culture of the Claudin-low breast cancer cells
M. Li (2016)
Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
D. Yardley (2016)
Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
C. O’Conor (2018)
Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells
Kyung Oh Jung (2017)
Expression profiling of DNA methylation-mediated epigenetic gene-silencing factors in breast cancer
Swayamsiddha Kar (2014)
Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.
A. Garcia-Gomez (2018)
Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings
S. Deshmukh (2017)
Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
Meghan Leary (2018)
Metastatic behavior of breast cancer subtypes.
H. Kennecke (2010)
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
T. Gruosso (2019)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
S. Loi (2013)
STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer
W. Wei (2014)
Abstract 1043: CSF-1R inhibitor prevented pre-metastatic lung niches in metastatic mammary tumor
T. Borin (2017)
The biology and function of exosomes in cancer.
R. Kalluri (2016)
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors.
Lauren L C Marotta (2011)
Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer
H. Kim (2014)
Phytochemicals inhibit the immunosuppressive functions of myeloid‐derived suppressor cells (MDSC): Impact on cancer and age‐related chronic inflammatory disorders
A. Salminen (2018)
IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.
Barbara Dillinger (2018)
Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
Andrew Sulaiman (2018)
Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
S. Burugu (2016)
The adaptive immunologic microenvironment in colorectal cancer: a novel perspective.
J. Galon (2007)
Reactive Astrocytes in Brain Metastasis
David Wasilewski (2017)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
N. Patsoukis (2015)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho (2015)
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Chul-yong Park (2014)
Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio
Ramakrishna Vadde (2015)
Exosomes are endogenous nanoparticles that can deliver biological information between cells.
D. Sun (2013)
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Yi Xiao (2019)
Calculation of an immunoscore based on extensive flow cytometry analysis of PBMCs from metastatic breast cancer patients treated with docetaxel alone or in combination with vaccine.
R. Donahue (2013)
[Role of PD-1/PD-L1 in microenvironment of breast cancer].
P. Ji (2019)
CD44+/CD24− phenotype predicts a poor prognosis in triple-negative breast cancer
Hui Wang (2017)
Binding and Fusion of Extracellular Vesicles to the Plasma Membrane of Their Cell Targets
Ilaria Prada (2016)
CoREST1 Promotes Tumor Formation and Tumor Stroma Interactions in a Mouse Model of Breast Cancer
S. Mazumdar (2015)
Exosome: emerging biomarker in breast cancer
Y. Jia (2017)
Interaction of EZH2 and P65 is involved in the arsenic trioxide-induced anti-angiogenesis in human triple-negative breast cancer cells
F. Jiang (2019)
The role of the myofibroblast in tumor stroma remodeling
Marcela Otranto (2012)
Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles.
K. Hu (2017)
A matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironment
M. Li (2016)
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis.
A. Becker (2016)
Dysfunctional T cell metabolism in the tumor microenvironment.
Kathryn E. Beckermann (2017)
Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.
Bojun Wang (2018)
The role of Wnt signaling in cancer and stem cells.
N. Reguart (2005)
Understanding and treating triple-negative breast cancer.
C. Anders (2008)
Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer.
Ramakrishna Vadde (2017)
Targeting the tumor microenvironment and T cell metabolism for effective cancer immunotherapy
H. Hope (2019)
CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.
M. J. Flister (2014)
Current challenges in the management of breast cancer brain metastases.
C. C. O'Sullivan (2017)
Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells.
Kirkland Sc (2009)
Molecular Pathways: Linking Tumor Microenvironment to Epithelial–Mesenchymal Transition in Metastasis
Hae-Yun Jung (2014)
Tumor-derived exosomes, microRNAs, and cancer immune suppression
M. Graner (2018)
In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment
Anne Helfen (2018)
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A Mani (2008)
Subtyping of triple‐negative breast cancer: Implications for therapy
V. Abramson (2015)
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
J. Yang (2010)
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
L. Racioppi (2019)
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.
S. Loi (2014)
A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer
S. Cowherd (2015)
A perspective on anti-EGFR therapies targeting triple-negative breast cancer.
K. Nakai (2016)
IL-1β induced methylation of the estrogen receptor ERα gene correlates with EMT and chemoresistance in breast cancer cells.
A. M. Jiménez-Garduño (2017)
Collagen I regulates the self‐renewal of mouse embryonic stem cells through α2β1 integrin‐ and DDR1‐dependent Bmi‐1
Han Na Suh (2011)
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.
S. Melo (2014)
The hypoxic tumour microenvironment
V. Petrova (2018)
DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment
P. Mathot (2017)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding (2018)
Hypoxia in cancer: significance and impact on clinical outcome
P. Vaupel (2007)
A chemotherapeutic approach targeting the acidic tumor microenvironment: combination of a proton pump inhibitor and paclitaxel for statistically optimized nanotherapeutics
S. Bhattacharya (2019)
Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology
J. Murphy (2018)
Metabolic regulation of T lymphocytes.
Nancie J. MacIver (2013)
Interactions between cancer stem cells and their niche govern metastatic colonization
Ilaria Malanchi (2012)
Intercellular nanovesicle‐mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth
Takayuki Kogure (2011)
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors
E. Irey (2019)
Exosomes: new players in cell-cell communication.
C. Bang (2012)
Cancer Stem Cells: The Architects of the Tumor Ecosystem.
B. Prager (2019)
Pattern of metastatic spread in triple-negative breast cancer
R. Dent (2008)
The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer
X. Zhou (2015)
The Biology of Cancer Exosomes: Insights and New Perspectives.
Carolina F. Ruivo (2017)
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
A. Stiff (2016)
The immune contexture in human tumours: impact on clinical outcome
W. Fridman (2012)
MHC‐controlled susceptibility to C3H‐MTV‐induced mouse mammary tumors is predominantly systemic rather than local
A. Dux (1987)
Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer
E. Holl (2019)
Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
M. Santoni (2018)
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
M. Udler (2009)
Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
Whitney R. Grither (2018)
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
C. Desmedt (2008)
Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy
F. Concha-Benavente (2017)
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
S. Ansieau (2008)
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
S. Loi (2015)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail (2013)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
F. Pagès (2018)
Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
Madhurima Das (2018)
Immune modulatory functions of EZH2 in the tumor microenvironment: implications in cancer immunotherapy.
Xiaohai Wang (2019)
Human MCS5A1 candidate breast cancer susceptibility gene FBXO10 is induced by cellular stress and correlated with lens epithelium‐derived growth factor (LEDGF)
X. Xu (2014)
Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma
P. Bendinelli (2017)
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian versus Western Populations.
Ching-Hsuan Chen (2019)
Structure-based derivation and intramolecular cyclization of peptide inhibitors from PD-1/PD-L1 complex interface as immune checkpoint blockade for breast cancer immunotherapy.
K. Zhou (2019)
Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
I. Li (2019)
The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.
Chakravarthy Garlapati (2019)
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
D. Márquez-Garbán (2019)
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
M. U. Mushtaq (2018)
Breast cancer subtypes predispose the site of distant metastases.
A. Soni (2015)
Molecular mechanisms of drug resistance
D. Longley (2005)
Evaluation of exosomal miR‐9 and miR‐155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells
V. Kia (2019)
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Y. Li (2017)
Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
Abel H. Y. Tan (2019)
The Hedgehog and Wnt signalling pathways in cancer
J. Taipale (2001)
T cell metabolism drives immunity
M. D. Buck (2015)
Cisplatin-resistant MDA-MB-231 cell-derived exosomes increase the resistance of recipient cells in an exosomal miR-423-5p-dependent manner.
B. Wang (2019)
Tumor microenvironment-mediated chemoresistance in breast cancer.
Kobra Velaei (2016)
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
M. Mittelbrunn (2011)
FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
M. Pan (2019)
MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60.
Lindsey N. Fix (2010)
Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses
Angélique Bobrie (2011)
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
L. Carey (2012)
Immunoscore provides a more accurate prognosis
P. Sidaway (2018)
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer
Barzin Y. Nabet (2017)
Novel Biomarkers for Personalized Cancer Immunotherapy
Y. Shindo (2019)
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.
L. M. Jones (2016)
In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Yunfei Li (2019)
Breast cancer cell-derived exosomes and macrophage polarization are associated with lymph node metastasis
Y. J. Piao (2018)
Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
Sundary Sormendi (2018)
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer
Ken Takai (2016)
mTOR Regulation of Glycolytic Metabolism in T Cells
R. Salmond (2018)
Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation
S. Deshmukh (2015)
Remodeling the Tumor Microenvironment Sensitizes Breast Tumors to Anti- Programmed Death-Ligand 1 Immunotherapy.
Renee T. Clift (2019)
Elements of cancer immunity and the cancer–immune set point
D. Chen (2017)
Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database
Ki-Tae Hwang (2018)
Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities
N. Willumsen (2017)
Alarming Burden of Triple‐Negative Breast Cancer in India
K. K. Thakur (2018)
Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes.
Maxim A. Moroz (2018)
Abstract 3929: The FAD-directed LSD1 specific inhibitor, INCB059872, inhibits cell migration and metastasis by suppressing premetastatic niche formation in a spontaneous metastasis mouse model
S. Lee (2018)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
B. Lehmann (2011)
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells.
K. O'Brien (2013)
ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas
A. Adams (2015)
LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response
I. Serganova (2018)
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells
Bethany N. Hannafon (2019)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
A. Rody (2008)
Cancer immunotherapy using checkpoint blockade
A. Ribas (2018)
Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.
A. Khramtsov (2010)
Hypoxia—ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum
L. Martin (1997)
Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells
C. Roma-Rodrigues (2014)
Hypoxia-Inducible Factor (HIF)-1 Regulatory Pathway and its Potential for Therapeutic Intervention in Malignancy and Ischemia
Jennifer E. Ziello (2007)
Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled
Yuliya Klymenko (2018)
The Prognostic Role of Ribosomal Protein S6 Kinase 1 Pathway in Patients With Solid Tumors: A Meta-Analysis
S. Zhang (2019)
Exosome mediated phenotypic changes in lung cancer pathophysiology.
Y. Shimada (2017)
Breast Cancer: Current Molecular Therapeutic Targets and New Players.
S. Nagini (2017)
Triple-negative breast cancer and the potential for targeted therapy
J. Jhan (2017)
Role of mTOR Signaling in Tumor Microenvironment: An Overview
Fabiana Conciatori (2018)
Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation
Nahyeon Kang (2019)
Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance
Anosheh Afghahi (2017)
The Role of the Extracellular Matrix in Cancer Stemness
Sameera Nallanthighal (2019)
Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance
Tianjian Yu (2017)
SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells.
W. Feng (2017)
Membrane vesicles as conveyors of immune responses
C. Théry (2009)
Innate and adaptive immune cells in the tumor microenvironment
T. Gajewski (2013)
MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
L. Zhao (2012)
Human adipose-derived mesenchymal stem cells promote breast cancer MCF7 cell epithelial-mesenchymal transition by cross interacting with the TGF-β/Smad and PI3K/AKT signaling pathways
Simeng Wu (2019)
Immunoscoring breast cancer: TILs remember what they target.
G. Curigliano (2014)
Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
P. M. M. Ozawa (2018)
This paper is referenced by
Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.
Rama Rao Malla (2020)
Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy.
H. Zubair (2020)
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Mingyang Tang (2020)